MinuteClinic providers can prescribe oral or injectable FDA approved weight-loss medications including: Contrave Liraglutide Orlistat Semaglutide Saxenda Tirzepatide FDA approved medications ensure safety, efficacy and rigorous quality standards that give our providers and patients the confidence they need
Many individuals in recovery experience insulin resistance, dysregulated appetite, weight instability, and hormonal imbalances that exacerbate fatigue, depression, and emotional volatility
Contraindications include personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Market Size & Forecast (2024-2031), By Product, USD Million Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Others Market Size & Forecast (2024-2031), By Route of Administration, USD Million Subcutaneous Oral Market Size & Forecast (2024-2031), By Application, USD Million Diabetes Obesity Others Market Size & Forecast (2024-2031), By End-user, USD Million Hospitals Specialty Clinics Home-care Settings Others Market Size & Forecast (2024-2031), By Region, USD Million North America US Canada Europe UK Germany France Italy Spain Rest of Europe Asia Pacific China India Japan Rest of Asia Pacific Latin America Middle East & Africa Key Strategic Questions Addressed What is the market size & forecast of the GLP-1 analogues market
